Thursday, December 3, 2009
Zogenix Closes $51 million in Series B Preferred Stock Financing ... - PR Newswire (press release)
Zogenix Closes $51 million in Series B Preferred Stock Financing ...PR Newswire (press release)The development of a potentially life-threatening serotonin syndrome may occur with triptans, including treatment with Sumavel DosePro, particularly during ...and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment